Association Between Intraocular Pressure and Risk Factors for Metabolic Syndrome in Korea
Jun Young Lee1, Myung Ho Cho1, Jiwoong Lee1,2
1Department of Ophthalmology, Pusan National University School of Medicine, Busan, Korea.
Background:
Glaucoma, the second leading cause of blindness worldwide, is associated with elevated intraocular pressure (IOP). Metabolic syndrome, a cluster of conditions that includes obesity, hypertension, hyperglycemia, and dyslipidemia, has been linked to increased IOP. This study investigated the relationship between IOP and metabolic syndrome risk factors in an adult Korean population.
Methods:
Data from 1,896 adults (aged 19-59 years) from the 2021 Korea National Health and Nutrition Examination Survey were analyzed. The exclusion criteria were age < 19 years; use of anti-glaucoma medications or anti-inflammatory eye drops; history of glaucoma, retinal, or refractive surgery; and a diagnosis of glaucoma. Metabolic syndrome risk factors, including blood pressure, fasting glucose, fasting insulin, homeostasis model assessment of insulin resistance, body mass index, abdominal obesity, triglycerides, and high-density lipoprotein cholesterol were examined for their association with ocular hypertension (OHT) using multivariate logistic regression.
Results:
Participants with metabolic syndrome (n = 383, 20.3%) demonstrated a higher mean IOP (16.05 ± 0.15 mmHg) compared with the normal group (15.33 ± 0.09 mmHg; P < 0.001). OHT was present in 33 patients (1.2%), and its prevalence did not differ significantly between the normal and metabolic syndrome groups. In multiple linear regression, risk factors, including hyperglycemia (P = 0.037) and hypertriglyceridemia (P = 0.027), were significantly associated with IOP. Abdominal obesity showed a strong association with OHT in multivariate analysis (odds ratio, 2.90; 95% confidence interval, 1.35-6.23; P = 0.007).
Conclusion:
Risk factors for metabolic syndrome, particularly abdominal obesity, were strongly associated with OHT. These findings emphasize the importance of regular IOP screening to prevent glaucoma progression in individuals with metabolic syndrome.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Coronary Artery Disease I: Introduction
Angle Closure Glaucoma: Treatment
